SS Innovations International (SSII) Capital Expenditures Growth (3y) (2020 - 2026)

SS Innovations International (SSII) Capital Expenditures Growth (3y) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (3y) (Qtr)
1 Abbott Laboratories 183.95 Bn 176.66 Bn 6.27 Bn 1.64%
2 Stryker 128.83 Bn 125.95 Bn 3.81 Bn 8.49%
3 Medtronic 108.81 Bn 99.59 Bn 6.41 Bn 8.89%
4 Boston Scientific 68.39 Bn 66.94 Bn 3.61 Bn 16.83%
5 Edwards Lifesciences 48.28 Bn 44.60 Bn 1.29 Bn 1.81%
6 Dexcom 28.39 Bn 27.27 Bn 750.30 Mn 0.84%
7 GE HealthCare Technologies 28.30 Bn 26.01 Bn 1.98 Bn 7.57%
8 Smith & Nephew 26.95 Bn 26.37 Bn - -
9 Koninklijke Philips 25.45 Bn 22.32 Bn 2.07 Bn 2.15%
10 SS Innovations International 784.03 Mn 760.42 Mn 5.33 Mn -8.99%

Historic Data

Download Data
DateValue
Mar 31, 2026 -8.99%
Mar 31, 2023 161.93%
Mar 31, 2020 -1.41%